NCT00002192View on ClinicalTrials.gov

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Interventions
DRUG

Rifapentine

DRUG

Ethambutol hydrochloride

DRUG

Clarithromycin

DRUG

Azithromycin

Trial Locations (1)

23666

Hampton Roads Med Specialists, Hampton

Sponsors

Collaborators (1)

Hoechst Marion Roussel
All Listed Sponsors
collaborator

Hoechst Marion Roussel

INDUSTRY

lead

Anderson Clinical Research

INDUSTRY

NCT00002192 - Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. | Biotech Hunter | Biotech Hunter